Mariam Afendy

1.9k total citations · 1 hit paper
16 papers, 1.5k citations indexed

About

Mariam Afendy is a scholar working on Epidemiology, Hepatology and Surgery. According to data from OpenAlex, Mariam Afendy has authored 16 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Epidemiology, 9 papers in Hepatology and 3 papers in Surgery. Recurrent topics in Mariam Afendy's work include Liver Disease Diagnosis and Treatment (13 papers), Liver Disease and Transplantation (5 papers) and Hepatitis C virus research (4 papers). Mariam Afendy is often cited by papers focused on Liver Disease Diagnosis and Treatment (13 papers), Liver Disease and Transplantation (5 papers) and Hepatitis C virus research (4 papers). Mariam Afendy collaborates with scholars based in United States, Australia and Germany. Mariam Afendy's co-authors include Zobair M. Younossi, Maria Stepanova, Yun Fang, Manirath Srishord, Youssef Younossi, Clare Nugent, Zachary Goodman, Rebecca Cable, Issah Younossi and Vikas Chandhoke and has published in prestigious journals such as Gastroenterology, Journal of Hepatology and Medicine.

In The Last Decade

Mariam Afendy

14 papers receiving 1.5k citations

Hit Papers

Changes in the Prevalence of the Most Common Causes of Ch... 2011 2026 2016 2021 2011 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mariam Afendy United States 10 1.3k 710 409 254 212 16 1.5k
Zahra Younoszai United States 16 1.5k 1.2× 955 1.3× 490 1.2× 206 0.8× 208 1.0× 32 1.7k
Munkhzul Otgonsuren United States 16 1.5k 1.2× 966 1.4× 549 1.3× 216 0.9× 278 1.3× 39 1.9k
Issah Younossi United States 21 1.9k 1.5× 1.3k 1.9× 618 1.5× 324 1.3× 263 1.2× 45 2.2k
Deirdre B Blissett United Kingdom 9 857 0.7× 388 0.5× 399 1.0× 146 0.6× 149 0.7× 16 1.1k
Natsu Fukui United States 8 1.6k 1.2× 529 0.7× 843 2.1× 295 1.2× 267 1.3× 19 1.9k
Mette Skalshøi Kjær Denmark 13 920 0.7× 415 0.6× 447 1.1× 310 1.2× 230 1.1× 31 1.4k
Michael H. Le United States 18 1.2k 1.0× 771 1.1× 357 0.9× 150 0.6× 185 0.9× 45 1.5k
Jian-Gao Fan China 4 915 0.7× 324 0.5× 383 0.9× 157 0.6× 200 0.9× 5 1.2k
Andrei Racila United States 20 2.1k 1.7× 1.3k 1.8× 734 1.8× 367 1.4× 300 1.4× 55 2.4k
Kai En Chan Singapore 16 843 0.7× 343 0.5× 422 1.0× 114 0.4× 135 0.6× 46 1.1k

Countries citing papers authored by Mariam Afendy

Since Specialization
Citations

This map shows the geographic impact of Mariam Afendy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mariam Afendy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mariam Afendy more than expected).

Fields of papers citing papers by Mariam Afendy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mariam Afendy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mariam Afendy. The network helps show where Mariam Afendy may publish in the future.

Co-authorship network of co-authors of Mariam Afendy

This figure shows the co-authorship network connecting the top 25 collaborators of Mariam Afendy. A scholar is included among the top collaborators of Mariam Afendy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mariam Afendy. Mariam Afendy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Younossi, Zobair M., Maria Stepanova, Rafael Esteban, et al.. (2017). Superiority of Interferon-Free Regimens for Chronic Hepatitis C. Medicine. 96(7). e5914–e5914. 37 indexed citations
2.
Locklear, Cameron T., Pegah Golabi, Natsu Fukui, et al.. (2017). Psoriasis is Independently Associated with Non-Alcoholic Fatty Liver Disease. Gastroenterology. 152(5). S1205–S1205.
3.
Stepanova, Maria, Leyla de Avila, Mariam Afendy, et al.. (2016). Direct and Indirect Economic Burden of Chronic Liver Disease in the United States. Clinical Gastroenterology and Hepatology. 15(5). 759–766.e5. 130 indexed citations
4.
Sayıner, Mehmet, Munkhzul Otgonsuren, Rebecca Cable, et al.. (2016). Variables Associated With Inpatient and Outpatient Resource Utilization Among Medicare Beneficiaries With Nonalcoholic Fatty Liver Disease With or Without Cirrhosis. Journal of Clinical Gastroenterology. 51(3). 254–260. 63 indexed citations
5.
Younossi, Zobair M., Maria Stepanova, Fatema Nader, et al.. (2015). 368 Improvement of Patient-Reported Outcomes in Older Patients With Chronic Hepatitis C (CH-C) Treated With Interferon- and Ribavirin-Free Sofosbuvir (SOF)-Containing Regimens. Gastroenterology. 148(4). S–979. 1 indexed citations
6.
Mishra, Alita, Munkhzul Otgonsuren, Chapy Venkatesan, et al.. (2013). The inpatient economic and mortality impact of hepatocellular carcinoma from 2005 to 2009: analysis of the US nationwide inpatient sample. Liver International. 33(8). 1281–1286. 28 indexed citations
7.
Younossi, Zobair M., Maria Stepanova, Mariam Afendy, Brian Lam, & Alita Mishra. (2013). Knowledge about infection is the only predictor of treatment in patients with chronic hepatitis C. Journal of Viral Hepatitis. 20(8). 550–555. 34 indexed citations
8.
Stepanova, Maria, et al.. (2012). 1335 SLEEP DISORDERS IN INDIVIDUALS WITH NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD). Journal of Hepatology. 56. S525–S525.
9.
Mishra, Alita, Munkhzul Otgonsuren, Chapy Venkatesan, et al.. (2012). 745 The Impact of Hepatocellular Carcinoma (HCC) in the United States (U.S.) From 2005 to 2009. Gastroenterology. 142(5). S–928. 1 indexed citations
10.
Younossi, Zobair M., Maria Stepanova, Mariam Afendy, et al.. (2011). Changes in the Prevalence of the Most Common Causes of Chronic Liver Diseases in the United States From 1988 to 2008. Clinical Gastroenterology and Hepatology. 9(6). 524–530.e1. 863 indexed citations breakdown →
11.
Stepanova, Maria, et al.. (2011). African Americans Are Less Likely to Have Clearance of Hepatitis C Virus Infection. Journal of Clinical Gastroenterology. 46(8). e62–e65. 13 indexed citations
13.
Younossi, Zobair M., Maria Stepanova, Mariam Afendy, et al.. (2011). 16 THE CHANGING FACE OF CHRONIC LIVER DISEASE (CLD) IN THE UNITED STATES: THE RISING EPIDEMIC OF NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD). Journal of Hepatology. 54. S8–S8. 6 indexed citations
14.
Mishra, Poonam, Clare Nugent, Arian Afendy, et al.. (2008). Apnoeic–hypopnoeic episodes during obstructive sleep apnoea are associated with histological nonalcoholic steatohepatitis. Liver International. 28(8). 1080–1086. 94 indexed citations
15.
Younossi, Zobair M., Mohammed Jarrar, Clare Nugent, et al.. (2008). A Novel Diagnostic Biomarker Panel for Obesity-related Nonalcoholic Steatohepatitis (NASH). Obesity Surgery. 18(11). 1430–1437. 212 indexed citations
16.
Nugent, Clare, Chunhong Bai, Hazem Elariny, et al.. (2008). Metabolic Syndrome after Laparoscopic Bariatric Surgery. Obesity Surgery. 18(10). 1278–1286. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026